Editorial: Biomarkers and immunotherapy for genitourinary tumors

Zeyu Han; Jianzhong Ai

doi:10.3389/fimmu.2024.1394170

Editorial: Biomarkers and immunotherapy for genitourinary tumors

Front Immunol. 2024 Mar 22:15:1394170. doi: 10.3389/fimmu.2024.1394170. eCollection 2024.

Authors

Zeyu Han¹, Jianzhong Ai¹

Affiliation

¹ Institute of Urology, Department of Urology, West China Hospital, Sichuan University, Chengdu, China.

No abstract available

Keywords: biomarkers; bladder cancer; genitourinary tumors; immunotherapy; prostate cancer; renal cell carcinoma.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers
Humans
Immunotherapy
Urinary Bladder Neoplasms* / pathology

Substances

Biomarkers

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the National Key R&D Program of China (2023YFC3403200), the National Natural Science Foundation of China (82070784 and 81702536), and the Science & Technology Department of Sichuan Province, China (2022JDRC0040).